Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inotiv, Inc. Director's Dealing 2012

Apr 11, 2012

34595_dirs_2012-04-11_a22e638a-4291-49d4-92e8-40fadda61820.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2012-04-09

Reporting Person: Chilton Anthony S (Director, CEO and President)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-04-09 Option to purchase common shares $1.38 A 25000 Acquired 2022-04-09 Common Shares (25000) Direct

Footnotes

F1: The options were granted pursuant to Dr. Chilton's Employment Agreement and vest and become exercisable on January 31, 2013.